A
Price
$114.25
Change
+$1.49 (+1.32%)
Updated
Jun 4, 12:57 PM (EDT)
Capitalization
42.66B
76 days until earnings call
BRKR
Price
$37.40
Change
+$0.67 (+1.82%)
Updated
Jun 3 closing price
Capitalization
12.93B
56 days until earnings call
Interact to see
Advertisement

A vs BRKR

Header iconA vs BRKR Comparison
Open Charts A vs BRKRBanner chart's image
Agilent Technologies
Price$114.25
Change+$1.49 (+1.32%)
Volume$500
Capitalization42.66B
Bruker
Price$37.40
Change+$0.67 (+1.82%)
Volume$1.8M
Capitalization12.93B
A vs BRKR Comparison Chart
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. BRKR commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and BRKR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (A: $112.76 vs. BRKR: $37.40)
Brand notoriety: A and BRKR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 63% vs. BRKR: 69%
Market capitalization -- A: $42.66B vs. BRKR: $12.93B
A [@Medical Specialties] is valued at $42.66B. BRKR’s [@Medical Specialties] market capitalization is $12.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileBRKR’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • BRKR’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than BRKR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while BRKR’s TA Score has 5 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 3 bearish.
  • BRKR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, both A and BRKR are a good buy in the short-term.

Price Growth

A (@Medical Specialties) experienced а +1.35% price change this week, while BRKR (@Medical Specialties) price change was +0.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.62%. For the same industry, the average monthly price growth was +3.58%, and the average quarterly price growth was +1.43%.

Reported Earning Dates

A is expected to report earnings on Aug 19, 2025.

BRKR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+1.62% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than BRKR($12.9B). A has higher P/E ratio than BRKR: A (34.82) vs BRKR (32.04). A YTD gains are higher at: -15.885 vs. BRKR (-36.130). A has higher annual earnings (EBITDA): 1.69B vs. BRKR (676M). BRKR has less debt than A: BRKR (1.38B) vs A (2.56B). A has higher revenues than BRKR: A (6.74B) vs BRKR (2.96B).
ABRKRA / BRKR
Capitalization42.7B12.9B331%
EBITDA1.69B676M250%
Gain YTD-15.885-36.13044%
P/E Ratio34.8232.04109%
Revenue6.74B2.96B227%
Total CashN/A488M-
Total Debt2.56B1.38B185%
FUNDAMENTALS RATINGS
A vs BRKR: Fundamental Ratings
A
BRKR
OUTLOOK RATING
1..100
759
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
4483
PRICE GROWTH RATING
1..100
6187
P/E GROWTH RATING
1..100
674
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (19) in the Biotechnology industry is somewhat better than the same rating for BRKR (66) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BRKR’s over the last 12 months.

A's Profit vs Risk Rating (62) in the Biotechnology industry is somewhat better than the same rating for BRKR (100) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BRKR’s over the last 12 months.

A's SMR Rating (44) in the Biotechnology industry is somewhat better than the same rating for BRKR (83) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BRKR’s over the last 12 months.

A's Price Growth Rating (61) in the Biotechnology industry is in the same range as BRKR (87) in the Medical Specialties industry. This means that A’s stock grew similarly to BRKR’s over the last 12 months.

BRKR's P/E Growth Rating (4) in the Medical Specialties industry is somewhat better than the same rating for A (67) in the Biotechnology industry. This means that BRKR’s stock grew somewhat faster than A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABRKR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 20 days ago
61%
Bullish Trend 1 day ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 13 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
44%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BRKR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JZ0.360.02
+4.65%
Jianzhi Education Technology Group Company Limited
SHOO24.800.55
+2.27%
Steven Madden Ltd
ESSA18.410.25
+1.38%
ESSA Bancorp
PKG194.081.82
+0.95%
Packaging Corp
WALD2.40-0.03
-1.23%
Waldencast plc

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been closely correlated with A. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
+1.82%
A - BRKR
78%
Closely correlated
+1.54%
RVTY - BRKR
73%
Closely correlated
+1.91%
MTD - BRKR
73%
Closely correlated
+2.22%
WAT - BRKR
68%
Closely correlated
+1.66%
IQV - BRKR
66%
Loosely correlated
+2.65%
More